Market Overview

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)

22.08 +0.25 (1.15%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
After-Hours
EPS:
REV:




Q1 2020
After-Hours
EPS:
REV:
0.34
85.474M



Q4 2019
After-Hours
EPS:
REV:
0.48
115.934M



Q3 2019
After-Hours
EPS:
REV:
0.52
102.996M
0.6
109.54M
0.54
102.14M
-10%
-6.76%
Q2 2019
After-Hours
EPS:
REV:
0.57
99.538M
0.57
108.67M
0.61
104.695M
7.02%
-3.66%
Q1 2019
After-Hours
EPS:
REV:
0.49
90.429M
0.47
103.87M
0.34
85.474M
-27.66%
-17.71%
Q4 2018
After-Hours
EPS:
REV:
0.44
88.435M
0.27
105.4M
0.48
115.934M
77.78%
9.99%
Q3 2018
After-Hours
EPS:
REV:
0.29
80.398M
0.39
101.84M
0.52
102.996M
33.33%
1.14%
Q2 2018
After-Hours
EPS:
REV:
0.32
75.829M
0.43
99.86M
0.57
99.538M
32.56%
-0.32%
Q1 2018
After-Hours
EPS:
REV:
0.19
57.576M
0.33
85.29M
0.49
90.429M
48.48%
6.03%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!